Samaneh Kazemifar1, Ana M Barragán Montero1,2, Kevin Souris2, Sara T Rivas2, Robert Timmerman1, Yang K Park1, Steve Jiang1, Xavier Geets2,3, Edmond Sterpin2,4, Amir Owrangi1. 1. Medical Artificial Intelligence and Automation (MAIA) Laboratory, Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA. 2. Institut de Recherche Expérimentale et Clinique, Center of Molecular Imaging, Radiotherapy and Oncology (MIRO), Université catholique de Louvain, Brussels, Belgium. 3. Department of Radiation Oncology, Cliniques universitaires Saint-Luc, Brussels, Belgium. 4. Department of Oncology, Laboratory of Experimental Radiotherapy, KULeuven, Leuven, Belgium.
Abstract
PURPOSE: The purpose of this study was to address the dosimetric accuracy of synthetic computed tomography (sCT) images of patients with brain tumor generated using a modified generative adversarial network (GAN) method, for their use in magnetic resonance imaging (MRI)-only treatment planning for proton therapy. METHODS: Dose volume histogram (DVH) analysis was performed on CT and sCT images of patients with brain tumor for plans generated for intensity-modulated proton therapy (IMPT). All plans were robustly optimized using a commercially available treatment planning system (RayStation, from RaySearch Laboratories) and standard robust parameters reported in the literature. The IMPT plan was then used to compute the dose on CT and sCT images for dosimetric comparison, using RayStation analytical (pencil beam) dose algorithm. We used a second, independent Monte Carlo dose calculation engine to recompute the dose on both CT and sCT images to ensure a proper analysis of the dosimetric accuracy of the sCT images. RESULTS: The results extracted from RayStation showed excellent agreement for most DVH metrics computed on the CT and sCT for the nominal case, with a mean absolute difference below 0.5% (0.3 Gy) of the prescription dose for the clinical target volume (CTV) and below 2% (1.2 Gy) for the organs at risk (OARs) considered. This demonstrates a high dosimetric accuracy for the generated sCT images, especially in the target volume. The metrics obtained from the Monte Carlo doses mostly agreed with the values extracted from RayStation for the nominal and worst-case scenarios (mean difference below 3%). CONCLUSIONS: This work demonstrated the feasibility of using sCT generated with a GAN-based deep learning method for MRI-only treatment planning of patients with brain tumor in intensity-modulated proton therapy.
PURPOSE: The purpose of this study was to address the dosimetric accuracy of synthetic computed tomography (sCT) images of patients with brain tumor generated using a modified generative adversarial network (GAN) method, for their use in magnetic resonance imaging (MRI)-only treatment planning for proton therapy. METHODS: Dose volume histogram (DVH) analysis was performed on CT and sCT images of patients with brain tumor for plans generated for intensity-modulated proton therapy (IMPT). All plans were robustly optimized using a commercially available treatment planning system (RayStation, from RaySearch Laboratories) and standard robust parameters reported in the literature. The IMPT plan was then used to compute the dose on CT and sCT images for dosimetric comparison, using RayStation analytical (pencil beam) dose algorithm. We used a second, independent Monte Carlo dose calculation engine to recompute the dose on both CT and sCT images to ensure a proper analysis of the dosimetric accuracy of the sCT images. RESULTS: The results extracted from RayStation showed excellent agreement for most DVH metrics computed on the CT and sCT for the nominal case, with a mean absolute difference below 0.5% (0.3 Gy) of the prescription dose for the clinical target volume (CTV) and below 2% (1.2 Gy) for the organs at risk (OARs) considered. This demonstrates a high dosimetric accuracy for the generated sCT images, especially in the target volume. The metrics obtained from the Monte Carlo doses mostly agreed with the values extracted from RayStation for the nominal and worst-case scenarios (mean difference below 3%). CONCLUSIONS: This work demonstrated the feasibility of using sCT generated with a GAN-based deep learning method for MRI-only treatment planning of patients with brain tumor in intensity-modulated proton therapy.
Authors: Bradley M Oborn; Stephen Dowdell; Peter E Metcalfe; Stuart Crozier; Radhe Mohan; Paul J Keall Journal: Med Phys Date: 2017-07-04 Impact factor: 4.071
Authors: Reza Farjam; Neelam Tyagi; Harini Veeraraghavan; Aditya Apte; Kristen Zakian; Margie A Hunt; Joseph O Deasy Journal: Med Phys Date: 2017-06-01 Impact factor: 4.071
Authors: Matteo Maspero; Mark H F Savenije; Anna M Dinkla; Peter R Seevinck; Martijn P W Intven; Ina M Jurgenliemk-Schulz; Linda G W Kerkmeijer; Cornelis A T van den Berg Journal: Phys Med Biol Date: 2018-09-10 Impact factor: 3.609
Authors: Anna M Dinkla; Jelmer M Wolterink; Matteo Maspero; Mark H F Savenije; Joost J C Verhoeff; Enrica Seravalli; Ivana Išgum; Peter R Seevinck; Cornelis A T van den Berg Journal: Int J Radiat Oncol Biol Phys Date: 2018-06-04 Impact factor: 7.038
Authors: Ana Barragán-Montero; Umair Javaid; Gilmer Valdés; Dan Nguyen; Paul Desbordes; Benoit Macq; Siri Willems; Liesbeth Vandewinckele; Mats Holmström; Fredrik Löfman; Steven Michiels; Kevin Souris; Edmond Sterpin; John A Lee Journal: Phys Med Date: 2021-05-09 Impact factor: 2.685
Authors: Minna Lerner; Joakim Medin; Christian Jamtheim Gustafsson; Sara Alkner; Lars E Olsson Journal: Front Oncol Date: 2022-01-10 Impact factor: 6.244
Authors: Sarah Hegarty; Nicholas Hardcastle; James Korte; Tomas Kron; Sarah Everitt; Sulman Rahim; Fiona Hegi-Johnson; Rick Franich Journal: Front Oncol Date: 2022-03-03 Impact factor: 6.244
Authors: Maria Elena Laino; Pierandrea Cancian; Letterio Salvatore Politi; Matteo Giovanni Della Porta; Luca Saba; Victor Savevski Journal: J Imaging Date: 2022-03-23